Daoquan Peng

机构：Central South University, Institute for Atherosclerosis Research, Second Xiangya Hospital of Central South University · ORCID：0000-0002-6171-4379

发表论文 145 篇 · 总被引 4176 次 · h-index 38

代表论文

• 2023 Chinese guideline for lipid management (2023 · Frontiers in Pharmacology · 被引 212)
• 2023 China Guidelines for Lipid Management (2023 · 老年心脏病学杂志：英文版 · 被引 109)
• Vericiguat for patients with heart failure and reduced ejection fraction across the risk spectrum: an individual participant data analysis of the VICTORIA and VICTOR trials (2025 · The Lancet · 被引 39)
• Chinese expert consensus on blood lipid management in patients with diabetes (2024 edition) (2024 · Journal of Translational Internal Medicine · 被引 33)
• Relation of Low-Density Lipoprotein Cholesterol, High-Sensitivity C-Reactive Protein, and Lipoprotein(a) Each to Future Cardiovascular Events and Death After Acute Coronary Syndrome on High-Intensity Statin Therapy: An Analysis of the Placebo Arm of ODYSSEY OUTCOMES (2025 · Circulation · 被引 23)
• The double-edged role and therapeutic potential of TREM2 in atherosclerosis (2024 · Biomarker Research · 被引 21)